Alain Fautrel
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 16
- Drug-Induced Hepatotoxicity and Protection 11
- Hepatology top 2%
- Liver physiology and pathology 10
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 6
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 5
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 4
-
- Liver Disease Diagnosis and Treatment 6
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Laurent CorcosAndré GuillouzoZiad Abdel‐RazzakBruno TurlinA. GuillouzoJean‐Charles GautierPhilippe BeaunePascal Loyer
- Cited by
- PharmacologyHepatologyOncology
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Alain Fautrel
70 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 121
- Pharmacology 649
- Hepatology 440
- Oncology 577
- Biochemistry 128
- Cancer Research 236
Countries citing papers authored by Alain Fautrel
This map shows the geographic impact of Alain Fautrel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Fautrel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Fautrel more than expected).
Fields of papers citing papers by Alain Fautrel
This network shows the impact of papers produced by Alain Fautrel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Fautrel. The network helps show where Alain Fautrel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alain Fautrel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 16 | |
| 3 | 2021 | 7 | |
| 4 | 2019 | 11 | |
| 5 | 2017 | 25 | |
| 6 | 2016 | 20 | |
| 7 | 2016 | 16 | |
| 8 | 2011 | 175 | |
| 9 | 2011 | 31 | |
| 10 | 2011 | 103 | |
| 11 | 2009 | 132 | |
| 12 | 2009 | 41 | |
| 13 | 2002 | 12 | |
| 14 | 2000 | 36 | |
| 15 | 1999 | 15 | |
| 16 | 1999 | 4 | |
| 17 | 1998 | 31 | |
| 18 | 1995 | 42 | |
| 19 | 1993 | 7 | |
| 20 | 1991 | 14 |
About Alain Fautrel
Alain Fautrel is a scholar working on Pharmacology, Hepatology and Biochemistry, having authored 71 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug-Induced Hepatotoxicity and Protection (11 papers), Liver physiology and pathology (10 papers), Drug Transport and Resistance Mechanisms (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Carcinogens and Genotoxicity Assessment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Pharmacology (649 citations), Hepatology (440 citations) and Oncology (577 citations). Alain Fautrel has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Laurent Corcos, André Guillouzo, Ziad Abdel‐Razzak, Bruno Turlin, A. Guillouzo, Jean‐Charles Gautier, Philippe Beaune, Pascal Loyer, Claire Guyomard and Christophe Chesné. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.